COVID-19 UPDATE - FIND OUT HOW WE CAN HELP YOU Read News
We focus on improving breast cancer survival rates by detecting cancers earlier and making treatment more effective and less invasive.
CE marked and FDA cleared
With the latest dedicated deep learning AI algorithms for breast cancer detection, Transpara® provides radiologists with clinically proven decision support tools. Transpara is trained on over 1 million trusted mammograms and can help with daily workflow and workload. To find out more, please contact us
NOT ALL AI IS THE SAME – FIND OUT MORE ABOUT HOW TRANSPARA CAN HELP YOU
Begin patient treatment earlier to improve survival rates
With an improvement in accuracy and reduction in false positives, Transpara aims to minimize unnecessary treatments, patient distress and associated costs
Transpara starts analysing mammograms immediately, providing objective information including level of suspicion to help the clinician with diagnosis
Radiologists face an ever-increasing workload so there is a need to work smarter whilst maintaining the highest quality levels when interpreting images. Transpara empowers radiologists to prioritise and focus on the most suspicious cases.
Client undergoes mammogram
Transpara analyses mammogram scan
Radiologist reads with support from Transpara, increasing confidence in decision
Make more accurate and consistent decision
Diagnostic Centers of America (DCA) and Boca Radiology Group has partnered with ScreenPoint Medical, Inc., to improve early detection and
Read moreWomen’s Imaging Associates and ScreenPoint Medical have announced today a strategic partnership to drive the earlier detection of breast cancer
Read moreAs the leaders in evidence based AI decision support, we are proud that Transpara technology which is FDA cleared for
Read moreRead how Transpara is helping radiologists with cancer detection, confidence and reducing unnecessary biopsies at the Albert Schweitzer hospital in
Read moreAccording to various international societies, most breast screening and diagnostic exams are likely to be delayed due to the current
Read moreScreenPoint Medical launches Transpara™ 1.6.0, the first breast AI solution for both 2D and 3D mammography in the USA. U.S.
Read more
